Ophthalmic Insert

Drug identity checked against registry records

Also recorded as OTX-TP

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular InsertNCT04061044OCULPhase 3Completed2020-02-10Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.